Heska Corporation (NASDAQ: HSKA) seeks to enhance shareholder value through exceptional business practices and operational performance, strong governance, responsible reporting, and effective communication and engagement. Heska actively engages the public market with timely reporting, relevant presentations and events, and other important financial data and filings.
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.
- Heska Corporation Second Quarter 2022 Earnings Call WebcastHeska Corporation Second Quarter 2022 Earnings Call Webcast (August 8, 2022 11:00 AM ET)
- Stifel 2022 Jaws & Paws ConferenceStifel 2022 Jaws & Paws Conference (June 1, 2022 3:00 PM ET)
- Heska 2022 Investor DayHeska 2022 Investor Day (May 17, 2022 11:00 AM ET)
- Heska Corporation First Quarter 2022 Earnings Call WebcastHeska Corporation First Quarter 2022 Earnings Call Webcast (May 9, 2022 11:00 AM ET)
- 2022 Annual Meeting of Stockholders2022 Annual Meeting of Stockholders (May 4, 2022 9:00 AM ET)
Please fill out the form below to receive company press releases and other information via email when they occur.